HIV-1 infected lymphoid organs upregulate expression and release of the cleaved form of uPAR that modulates chemotaxis and virus expression.
Cell-associated receptor for urokinase plasminogen activator (uPAR) is released as both full-length soluble uPAR (suPAR) and cleaved (c-suPAR) form that maintain ability to bind to integrins and other receptors, thus triggering and modulating cell signaling responses. Concerning HIV-1 infection, pla...
Guardado en:
Autores principales: | Manuela Nebuloni, Lidia Zawada, Angelita Ferri, Antonella Tosoni, Pietro Zerbi, Massimo Resnati, Guido Poli, Luca Genovese, Massimo Alfano |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/19e7e41797ab40648d9d1314c5d04b2d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clathrin and LRP-1-independent constitutive endocytosis and recycling of uPAR.
por: Katia Cortese, et al.
Publicado: (2008) -
Co-depletion of cathepsin B and uPAR induces G0/G1 arrest in glioma via FOXO3a mediated p27 upregulation.
por: Sreelatha Gopinath, et al.
Publicado: (2010) -
Development of AE147 Peptide-Conjugated Nanocarriers for Targeting uPAR-Overexpressing Cancer Cells
por: Park JY, et al.
Publicado: (2021) -
The Urokinase Receptor (uPAR) as a “Trojan Horse” in Targeted Cancer Therapy: Challenges and Opportunities
por: Virginia Metrangolo, et al.
Publicado: (2021) -
Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin
por: Oh F, et al.
Publicado: (2018)